CORC

在结果中检索

CORC

浏览/检索结果: 共539条，第1-10条 帮助

限定条件    
已选(0)清除 条数/页：   排序方式：
FTIR trend term removal method based on GA and MSAC algorithms 会议论文
Nantong, PEOPLES R CHINA, SEP 17-19, 2022
作者:  Yan B(闫浡);  Fang JY;  Chen H(陈豪);  Li SH(李帅辉)
收藏  |  浏览/下载：0/0  |  提交时间：2023/10/26
Impact of meteorological factors on the COVID-19 transmission: A multi-city study in China 会议论文
作者:  Liu, Jiangtao;  Zhou, Ji;  Yao, Jinxi;  Zhang, Xiuxia;  Li, Lanyu
收藏  |  浏览/下载：17/0  |  提交时间：2020/12/18
Research on the design of wearable equipment for intelligent emotion detection for empty nest elderly 会议论文
2019ICMD
作者:  Xue, Yan-min;  Ge, Chang;  Xu, Shi-yi;  Zhang, Xu-yang;  Xiao, Bo-xin
收藏  |  浏览/下载：36/0  |  提交时间：2019/12/20
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载：43/0  |  提交时间：2019/12/05
Prognosis assessment of acute-on-chronic liver failure in patients with hepatitis B virus-related cirrhosis requires specific criteria 会议论文
作者:  Gu Wenyi;  Deng, Guohong;  Zheng, Xin;  Chen, Jinjun;  Wang, Xian-bo
收藏  |  浏览/下载：88/0  |  提交时间：2019/12/05
The sixth visual object tracking VOT2018 challenge results 会议论文
15th European Conference on Computer Vision, ECCV 2018, Munich, Germany, 2018-09-08
作者:  Kristan, Matej;  Leonardis, Ale;  Matas, Jií;  Felsberg, Michael;  Pflugfelder, Roman
收藏  |  浏览/下载：140/0  |  提交时间：2019/12/02
THE EFFICACY AND SAFETY OF RAVIDASVIR COMBINED WITH DANOPREVIR IN THE 12-WEEK ORAL REGIMEN FOR TREATMENT-NAIVE HCV GENOTYPE 1 ADULT PATIENTS WITHOUT CIRRHOSIS IN CHINA: PHASE II/III CLINICAL TRIAL 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Zheng, Sujun;  Guan, Yujuan;  Sheng, Jifang
收藏  |  浏览/下载：34/0  |  提交时间：2019/12/05
PASiam: Predicting attention inspired siamese network, for space-borne satellite video tracking 会议论文
作者:  Shao, Jia;  Du, Bo;  Wu, Chen;  Pingkun, Yan
收藏  |  浏览/下载：2/0  |  提交时间：2019/12/05
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载：36/0  |  提交时间：2019/12/05
THE EFFICACY AND SAFETY OF RAVIDASVIR COMBINED WITH DANOPREVIR IN THE 12-WEEK ORAL REGIMEN FOR TREATMENT-NAIVE HCV GENOTYPE 1 ADULT PATIENTS WITHOUT CIRRHOSIS IN CHINA: PHASE II/III CLINICAL TRIAL 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Zheng, Sujun;  Guan, Yujuan;  Sheng, Jifang
收藏  |  浏览/下载：32/0  |  提交时间：2019/12/05

©版权所有 ©2017 CSpace - Powered by CSpace